BSX icon

Boston Scientific

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 86.6%
Negative

Positive
Zacks Investment Research
10 hours ago
Here's How Boston Scientific Is Expanding Its Global Growth
BSX expands global reach with strong APAC growth, FARAPULSE momentum and new approvals driving gains across Europe and China.
Here's How Boston Scientific Is Expanding Its Global Growth
Negative
Zacks Investment Research
yesterday
Should You Buy, Hold or Sell BSX Stock Amid Cardiovascular Boom?
Boston Scientific rides on cardiovascular device growth with FARAPULSE and WATCHMAN momentum, but margin pressure and weaker estimates cloud the outlook.
Should You Buy, Hold or Sell BSX Stock Amid Cardiovascular Boom?
Neutral
GlobeNewsWire
2 days ago
Belo Sun to Commence Technical Studies on Volta Grande Gold Project
TORONTO, May 12, 2026 (GLOBE NEWSWIRE) -- Belo Sun Mining Corp. (“Belo Sun” or “Company”) (TSX: BSX, OTCQB: BSXGF) today announces the commencement of technical studies relating to its Volta Grande Gold Project (“Project”) located in Pará State, Brazil, with the engagement of a mining consultant and the hiring of a Engineering Director.
Belo Sun to Commence Technical Studies on Volta Grande Gold Project
Positive
Seeking Alpha
3 days ago
Boston Scientific: Poised To Rebound With The Healthcare Sector, But When?
Boston Scientific Corporation is a leading medtech innovator facing recent share price underperformance due to market share erosion in electrophysiology and sector-wide sentiment shifts. Despite competitive pressures, BSX maintains strong leadership in PFA, with Watchman and neuromodulation as promising growth drivers and a robust pipeline supported by strategic M&A. Management has improved operating and net margins, reduced short-term debt, and achieved ROIC above WACC, signaling efficient capital allocation and resilience despite slowing revenue growth.
Boston Scientific: Poised To Rebound With The Healthcare Sector, But When?
Positive
Zacks Investment Research
6 days ago
BSX Q1 Neuromodulation Sales Rise 15% Y/Y: What Lies Behind the Growth?
Boston Scientific's Neuromodulation unit posts 15% organic sales growth in Q1, fueled by pain management gains, the acquisition of Nalu and momentum in Intracept.
BSX Q1 Neuromodulation Sales Rise 15% Y/Y: What Lies Behind the Growth?
Positive
Seeking Alpha
6 days ago
Allspring Large Cap Growth Fund Q1 2026 Attribution And Adjustments
Quanta Services, Inc. stock performed well during the quarter following a strong earnings beat, record backlog, and growing recognition that power infrastructure has become a critical bottleneck in the build-out of AI. Vertiv Holdings Co. benefited from a sharp acceleration of growth in its order book and continued ability to win market share from legacy players in the cooling space. During the quarter, EMCOR Group, Inc. reported record results that underscored strong execution and demand across core end markets.
Allspring Large Cap Growth Fund Q1 2026 Attribution And Adjustments
Negative
Reuters
7 days ago
US FDA issues recall of Boston Scientific heart devices
Boston Scientific has issued an urgent recall to correct several heart devices after the U.S. Food ​and Drug Administration classified the action as its ‌most serious recall, the regulator said on Thursday.
US FDA issues recall of Boston Scientific heart devices
Neutral
GlobeNewsWire
7 days ago
Belo Sun Mining Corp. Begins Trading on OTCQX
TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- Belo Sun Mining Corp. (“Belo Sun” or the “Company”) (TSX: BSX; OTCQX: BSXGF) is pleased to announce that effective today, its common shares have qualified to trade on the OTCQX® Best Market (“OTCQX”) in the United States under the ticker “BSXGF”. The Company's common shares will continue to trade on the TSX Exchange under the symbol “BSX”.
Belo Sun Mining Corp. Begins Trading on OTCQX
Neutral
Seeking Alpha
7 days ago
Diamond Hill Small-Mid Cap Strategy Q1 2026 Portfolio Activity
We do not believe Humana's current share price reflects the company's earnings power, and as industry conditions normalize, we believe it can return to target margins over the long term. We initiated a position in Antero Resources, a natural gas exploration and production company, to gain exposure given our constructive long-term outlook for US natural gas. We exited our position in First Advantage, a leader in the background check space, to pursue other opportunities with less macro exposure and AI-disruption concerns.
Diamond Hill Small-Mid Cap Strategy Q1 2026 Portfolio Activity
Neutral
PRNewsWire
8 days ago
Penumbra, Inc. Reports First Quarter 2026 Financial Results
ALAMEDA, Calif., May 6, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the first quarter ended March 31, 2026.
Penumbra, Inc. Reports First Quarter 2026 Financial Results